Clinical trial Recruiting at 26 sites Observational Ages 16 and up

Predicting STIs in people using HIV prevention medication in Spain

Official title: Development of a Predictive Model for Sexually Transmitted Infections in Individuals Using Pre-Exposure Prophylaxis for HIV in Spain

Run by Hospital Universitario de Valme · NCT06860945 · Data updated 2026-11-12

This study is trying to see if a new way to predict sexually transmitted infections can help people using HIV prevention medication in Spain stay healthier.

Quick facts

Study typeObservational
Ages16 Years and up
SexAll
Enrollment9000 (estimated)
SponsorHospital Universitario de Valme
Academic / other
Locations26 sites (Almería and 25 other locations)
StatusRecruiting
StartedJanuary 1, 2025
Main results expectedJune 30, 2025
Study endsJanuary 1, 2026
Registry record updatedMarch 6, 2025
Trial IDNCT06860945 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 16 and older who are using PrEP and meet specific risk criteria.

Probably not a fit

Patients who are not using PrEP or do not meet the eligibility criteria will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to develop and validate a predictive model for acquiring sexually transmitted infections (STIs) among individuals using pre-exposure prophylaxis (PrEP) for HIV in Spain. It involves an ambispective cohort design across 23 hospitals, where all PrEP users will be monitored quarterly following national protocols. At each visit, various STIs will be diagnosed using different sample types, and the primary outcome will be whether an STI is developed. The study will include individuals who have initiated PrEP and meet specific eligibility criteria.

Why it matters

Potential benefit: If successful, this study could enhance the ability to predict and prevent STIs in individuals using PrEP, leading to better health outcomes.

How similar studies have gone: While predictive modeling in this context is relatively novel, similar studies in other regions have shown promise in improving STI prevention strategies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All individuals with documented initiation of oral PrEP (daily or event-driven regimens), who have collected the medication at least once and have taken at least one pill, will be included in the study.

The approved criteria for the use of oral PrEP in Spain, as recommended by the Spanish Gesida guidelines (GeSIDA. Recomendaciones sobre la Profilaxis Pre-Exposición para la Prevención de la Infección por VIH en España. Marzo 2023. Available at http://.gesida-seimc.org/category/guias-clinicas/otras-guias-vigentes/), are as follows:

* People without HIV infection at the time of cohort inclusion
* Age ≥ 16 yr who meet the following criteria:
* MSM and transgender women with at least two of the following criteria during the last year: \> 10 sexual partners; Condomless anal sex; Chemsex; PEP; ≥ 1 STI
* Sex worker women who report non-habitual use of condoms.
* Cisgender males/females, who report condomless and present at least two of the same criteria as MSM and transgender.
* PWID with unsafe injection practices

Exclusion Criteria: none

\-

Where it's running

  • Hospital Universitario de Torrecárdenas
    Almería, Spain
    Recruiting
  • Hospital Universitario Puerto Real
    Cadiz, Spain
    Recruiting
  • Hospital Universitario Santa Lucía
    Cartagena, Spain
    Recruiting
  • hospital Universitario reina Sofía
    Córdoba, Spain
    Recruiting
  • Hospital Virgen de la Luz
    Cuenca, Spain
    Recruiting
  • Hospital Universitario de Elche
    Elche, Spain
    Recruiting
Show 20 more locations
  • Hospital Clínico Universitario San Cecilio
    Granada, Spain
    Recruiting
  • Hospital Universitario Virgen de las Nieves
    Granada, Spain
    Recruiting
  • Hospital Universitario Juan Ramón Jiménez
    Huelva, Spain
    Recruiting
  • Complejo Hospitalario de Jaén
    Jaén, Spain
    Recruiting
  • Hospital de Jerez de la Frontera
    Jerez de la Frontera, Spain
    Recruiting
  • Hospital Universitario de Bellvitge
    L'Hospitalet de Llobregat, Spain
    Recruiting
  • Hospital Universitario Dr. Negrín
    Las Palmas de Gran Canaria, Spain
    Recruiting
  • Centro Sanitario Sandoval
    Madrid, Spain
    Recruiting
  • Hospital Fundación Jiménez Díaz
    Madrid, Spain
    Recruiting
  • Hospital Universitario Infanta Leonor
    Madrid, Spain
    Recruiting
  • Hospital Universitario La Princesa
    Madrid, Spain
    Recruiting
  • Hospital Regional Universitario de Málaga
    Málaga, Spain
    Recruiting
  • Hospital Universitario Virgen de la Victoria
    Málaga, Spain
    Recruiting
  • Hospital Universitario Virgen de la Arrixaca
    Murcia, Spain
    Recruiting
  • Hospital Universitario Marqués de Valdecilla
    Santander, Spain
    Recruiting
  • Hospital Universitario Virgen de la Macarena
    Seville, Spain
    Recruiting
  • Hospital Universitario Virgen de Valme
    Seville, Spain
    Recruiting
  • Hospital Universitario Virgen del Rocío
    Seville, Spain
    Recruiting
  • Hospital Universitario de Valladolid
    Valladolid, Spain
    Recruiting
  • Hospital Universitario Álvaro Cunqueiro
    Vigo, Spain
    Recruiting

Study contacts

  • Principal investigator: Anaïs Corma-Gómez, MD, PhD — Hospital Clínico Universitario de Valencia
  • Study coordinator: Anaïs Corma-Gómez
  • Email: anais.corgo@gmail.com
  • Phone: +34676170692

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Linking Youth to PrEP Services for HIV Prevention

    This project tests a community-based PrEP delivery plus a supportive mobile app to help teens and young adults steadily use PrEP.

    Recruiting at 4 sites Westat · San Francisco, California and 3 other locations · NCT07438041

  • PrEP Optimization Through Enhanced Continuum Tracking (PrOTECT AL)

    This project will test a real-time PrEP care dashboard and implementation strategies at seven Alabama clinics to see if they increase PrEP coverage and equity among people at risk for HIV.

    Recruiting University of Alabama at Birmingham · Birmingham, Alabama · NCT07231640

  • ICONA Prevention Program for People Using PrEP in Italy

    This program will follow HIV-negative adults in Italy who are starting or already using PrEP to see how well PrEP prevents HIV, how tolerable it is, and what helps or hinders people from staying on it.

    Recruiting at 18 sites Fondazione ICONA · Chieti, Abruzzo and 52 other locations · NCT07186244

  • Bringing PrEP to a family planning clinic

    This study tests whether offering PrEP in a family planning clinic is acceptable to patients and feasible for providers in Rhode Island.

    Recruiting Women and Infants Hospital of Rhode Island · Providence, Rhode Island · NCT06930508

  • Evaluating a PrEP implementation strategy for incarcerated individuals

    This study is testing a new way to help people in jail get access to PrEP and learn about HIV prevention to see if it can improve their health outcomes.

    Recruiting University of Texas Southwestern Medical Center · Dallas, Texas · NCT06919419

  • Project SHIELD 2.0: Police Education to Support Public Health in Kentucky

    Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.

    Recruiting Johns Hopkins Bloomberg School of Public Health · Lexington, Kentucky · NCT07804121

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.